Mr. Speaker, the member knows that drug shortages are not just a local, regional, or national problem but are a global issue, and we take them very seriously. That is why we have worked for quite some time with the provinces and territories and drug manufacturers on a pan-Canadian strategy to address this issue. It is working well, but we are concerned about making sure that it is the best it can be.
We have launched consultations to see if we do need to move from a voluntary approach to a mandatory approach. The member is welcome to provide input on that process.